Skip to main content
. 2022 May 26;19:47–55. doi: 10.1016/j.ijpddr.2022.05.004

Table 1.

Anti-protozoal activity and toxicity of pyridazines and tetrahydrophthalazinones.

Cmpd R1 R2 Y M.W. cLogPa tPSAa IC50 (nM)
G.l.b MRC-5c
11 NO2 MeO Y1 531.6 3.3 127.7 0.5 ± 0.2 >6.4 × 104
12 NO2 cyclopentyloxy Y2 585.7 4.6 127.7 9.3 ± 0.6 >6.4 × 104
13 NO2 Image 2 Y2 652.7 5.0 170.8 1.2 ± 0.4 >6.4 × 104
14 NO2 Image 3 Y2 637.7 4.9 136.9 1.0 ± 0.5 >6.4 × 104
15 NO2 Image 4 Y2 608.7 3.8 140.6 6.8 ± 1.5 15,000 ± 11,000
16 NO2 Image 5 Y2 637.7 4.9 136.9 2.8 ± 0.8 49,000 ± 21,000
17 NO2 Image 6 Y2 608.7 3.9 140.6 0.5 ± 0.1 >6.4 × 104
18 NO2 MeO Y3 479.5 2.1 127.7 0.2 ± 0.1 >6.4 × 104
19 NO2 Cl Y3 483.9 2.9 118.5 19.0 ± 3.2 >6.4 × 104
20 H MeO Y3 434.5 2.1 84.5 930 ± 100 >6.4 × 104
3 (MET) - - - 171.2 −0.5 81.2 800 ± 100 -
Tamoxifen - - - 371.5 6.8 12.5 - 11,000 ± 5,000

3.2.

MET: metronidazole; G.l.: Giardia lamblia.

a

cLogP, tPSA are calculated using Collaborative Drug Discovery (CDD) Vault.

b

mean values ± standard errors are given for quadruplicates, the standard errors correspond to the 95% confidence intervals as calculated via the logit-log algorithm.

c

mean values ± standard deviations, n ≥ 2.